The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Response to anti-PD1/PDL1 therapy in patients with metastatic desmoplastic melanoma.
 
Zeynep Eroglu
No Relationships to Disclose
 
Dae Won Kim
No Relationships to Disclose
 
Douglas Buckner Johnson
Consulting or Advisory Role - Boston Scientific
 
Alain Patrick Algazi
Research Funding - GlaxoSmithKline
 
Rodrigo Ramella Munhoz
No Relationships to Disclose
 
Elizabeth Liniker
No Relationships to Disclose
 
Ben Kong
No Relationships to Disclose
 
Neharika Khurana
No Relationships to Disclose
 
Bartosz Chmielowski
Honoraria - Amgen; Merck
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma (Inst); Genentech (Inst); Lilly (Inst); Merck/Schering Plough (Inst)
Speakers' Bureau - Bristol-Myers Squibb; Genentech/Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech/Roche; Lilly; Merck
 
Jeffrey Alan Sosman
Consulting or Advisory Role - Merck
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline
 
Richard A Scolyer
No Relationships to Disclose
 
Matteo S. Carlino
No Relationships to Disclose
 
Michael Andrew Postow
Consulting or Advisory Role - Amgen; Bioconnections LLC; FirstWord; Millennium
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Wen-Jen Hwu
No Relationships to Disclose
 
Georgina V. Long
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MERCK; Novartis; Provectus; Roche/Genentech
Travel, Accommodations, Expenses - Roche/Genentech
 
Antoni Ribas
Stock and Other Ownership Interests - Compugen; Kite, a Gilead company
Consulting or Advisory Role - Amgen; Genentech/Roche; GlaxoSmithKline; Merck; Novartis
Research Funding - Merck Sharp & Dohme (Inst)